Variant report

Variant	esv34187
Chromosome Location	chr10:117857916-117894117
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr10:117785563..117786434-chr10:117879960..117880895,2	MCF-7	breast:
2	chr10:117862592..117864275-chr10:118031687..118033888,2	MCF-7	breast:
3	chr10:117893470..117897343-chr10:117899899..117904447,5	MCF-7	breast:
4	chr10:117873712..117876077-chr10:117876946..117879196,2	K562	blood:
5	chr10:117891262..117893332-chr10:117898667..117900284,2	MCF-7	breast:
6	chr10:117890330..117892125-chr10:118026371..118028506,2	MCF-7	breast:
7	chr10:117873712..117876077-chr10:117876946..117879196,2	K562	blood:
8	chr10:117892801..117895046-chr10:118029774..118031284,2	MCF-7	breast:
9	chr10:117858148..117861915-chr10:118033235..118035636,3	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000151892	chromatin interactions

Extended variants
information (count: 1507 )
Associated
traits (count: 69 )

Variant overlapped rSNPs/rCNVs (count:1507 , 50 per page) page: 1 2 3 4 5 6 7 ... 31

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs3781510	chr10:117857916-117857917	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs557604847	chr10:117857947-117857948	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs572572260	chr10:117857948-117857949	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs76727122	chr10:117857969-117857970	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs191782383	chr10:117857988-117857989	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs79952537	chr10:117858043-117858044	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs181380949	chr10:117858066-117858067	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs3781511	chr10:117858145-117858146	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs531046804	chr10:117858176-117858177	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs375055085	chr10:117858184-117858185	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs546641408	chr10:117858226-117858227	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs74683191	chr10:117858236-117858237	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs80322022	chr10:117858258-117858259	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs186308683	chr10:117858284-117858285	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs190769359	chr10:117858290-117858291	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs144195923	chr10:117858294-117858295	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs567782927	chr10:117858318-117858319	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs539274261	chr10:117858376-117858377	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs371700545	chr10:117858387-117858388	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs572607594	chr10:117858401-117858402	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs570052967	chr10:117858445-117858446	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs78862610	chr10:117858455-117858456	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs79825281	chr10:117858464-117858465	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs573329554	chr10:117858470-117858471	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs182279842	chr10:117858479-117858480	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs558752159	chr10:117858495-117858496	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs535104907	chr10:117858519-117858520	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs563842546	chr10:117858525-117858526	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs386747951	chr10:117858545-117858546	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs11197531	chr10:117858547-117858548	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs186075553	chr10:117858571-117858572	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs116723860	chr10:117858573-117858574	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs59066664	chr10:117858635-117858636	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs562144359	chr10:117858669-117858670	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs574775642	chr10:117858689-117858690	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs529306996	chr10:117858695-117858696	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs550921604	chr10:117858726-117858727	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs558376976	chr10:117858754-117858755	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs146069202	chr10:117858765-117858766	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs11197532	chr10:117858773-117858774	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs564875403	chr10:117858778-117858779	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs566371724	chr10:117858790-117858791	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs533715508	chr10:117858793-117858794	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs555075825	chr10:117858856-117858857	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs573366671	chr10:117858861-117858862	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs374401617	chr10:117858862-117858863	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs113269039	chr10:117858870-117858871	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs575854898	chr10:117858883-117858884	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs190976568	chr10:117858902-117858903	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs558484220	chr10:117858928-117858929	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:69)

Disease	PMID	Source
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Prostate cancer	18632612	CNVD
Cockayne syndrome	18421352	CNVD
Glioblastoma	16823260	CNVD
Medulloblastoma	16968546	CNVD
Neuroblastoma	17533364	CNVD
Squamous cell cancer	21044232	CNVD
Glioma	21971842	CNVD
Cancer	21637783	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Lung cancer	18438408	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21785460	CNVD
Acute myeloid leukemia	20729466	CNVD
Paraganglioma	17535989	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Pulmonary chondroma	17535989	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	17387387	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	16573809	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	16608533	CNVD
small cell lung cancer	20016488	CNVD
Glioblastoma multiforme	17002787	CNVD
Breast cancer	17393978	CNVD
Ovarian cancer	21720365	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Cornelia de Lange syndrome	24599119	CNVD
T-cell lymphomas	19863542	CNVD
Breast cancer	16397240	CNVD
Urothelial carcinoma	21177765	CNVD
Chronic lymphocytic leukemia	18645599	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Hepatocellular carcinoma	16750200	CNVD
Barrett''s syndrome	19417022	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Neuroticism	17667963	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21509527	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:292 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:117849200-117858400	Weak transcription	Stomach Smooth Muscle	stomach
2	chr10:117854600-117858000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr10:117855200-117859200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
4	chr10:117855400-117859000	Enhancers	Fetal Muscle Leg	muscle
5	chr10:117855600-117859200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
6	chr10:117856000-117859400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
7	chr10:117856400-117858200	Enhancers	Brain Substantia Nigra	brain
8	chr10:117856400-117859200	Enhancers	HSMMtube	muscle
9	chr10:117856600-117858400	Enhancers	Brain Cingulate Gyrus	brain
10	chr10:117856800-117858000	Enhancers	Brain Hippocampus Middle	brain
11	chr10:117856800-117858200	Enhancers	Fetal Muscle Trunk	muscle
12	chr10:117856800-117858400	Enhancers	Brain Inferior Temporal Lobe	brain
13	chr10:117856800-117858600	Enhancers	Brain Anterior Caudate	brain
14	chr10:117856800-117859200	Enhancers	Duodenum Smooth Muscle	Duodenum
15	chr10:117857000-117867600	Weak transcription	Liver	Liver
16	chr10:117857000-117872800	Weak transcription	HSMM	muscle
17	chr10:117857200-117858400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
18	chr10:117857200-117858400	Enhancers	Fetal Stomach	stomach
19	chr10:117857200-117859200	Enhancers	Fetal Kidney	kidney
20	chr10:117857200-117859600	Enhancers	Colon Smooth Muscle	Colon
21	chr10:117857400-117858200	Enhancers	Psoas Muscle	Psoas
22	chr10:117857400-117859800	Enhancers	Rectal Smooth Muscle	rectum
23	chr10:117857600-117858200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
24	chr10:117857600-117858600	Weak transcription	Brain Angular Gyrus	brain
25	chr10:117857600-117858600	Bivalent Enhancer	Brain Germinal Matrix	brain
26	chr10:117857800-117860200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
27	chr10:117858000-117858600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
28	chr10:117858000-117859000	Enhancers	Adipose Nuclei	Adipose
29	chr10:117858200-117858600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
30	chr10:117858200-117859200	Enhancers	Skeletal Muscle Male	skeletal muscle
31	chr10:117858200-117872200	Weak transcription	Fetal Muscle Trunk	muscle
32	chr10:117858400-117858600	Enhancers	Brain Hippocampus Middle	brain
33	chr10:117858400-117858600	Enhancers	Stomach Smooth Muscle	stomach
34	chr10:117858400-117858800	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
35	chr10:117858400-117863400	Weak transcription	Fetal Stomach	stomach
36	chr10:117858600-117858800	Enhancers	Brain Angular Gyrus	brain
37	chr10:117858600-117859600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
38	chr10:117858600-117863200	Weak transcription	Stomach Smooth Muscle	stomach
39	chr10:117858800-117859600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
40	chr10:117859000-117860600	Weak transcription	Fetal Muscle Leg	muscle
41	chr10:117859200-117861200	Weak transcription	HSMMtube	muscle
42	chr10:117859200-117863400	Weak transcription	Duodenum Smooth Muscle	Duodenum
43	chr10:117859200-117864800	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
44	chr10:117859200-117875000	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
45	chr10:117859600-117861400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
46	chr10:117860200-117862000	Strong transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
47	chr10:117860600-117864400	Enhancers	Fetal Muscle Leg	muscle
48	chr10:117861000-117861800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
49	chr10:117861200-117861800	Enhancers	HSMMtube	muscle
50	chr10:117861400-117861800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links